VCP ScannerFree US Stock Screener & Financial AnalysisFree US Stock Screener
ScreenerThemes
DCF ValuationCalculate intrinsic value of US stocks
Market ValuationBuffett indicator, CAPE & macro gauges
Total ReturnSee dividends + price return history
DCA CalculatorSimulate recurring buys & compounding
Earnings
FAANG & Tech
AAPL vs MSFTNVDA vs AMDGOOGL vs META
Cloud & Cyber
CRM vs NOWCRWD vs PANWSNOW vs DDOG
Consumer & Auto
TSLA vs FAMZN vs WMTNFLX vs DIS
Finance & Crypto
JPM vs BACV vs MACOIN vs MSTR
Pharma & Energy
LLY vs NVOJNJ vs PFEXOM vs CVX
Compare Any Stocks...
WatchlistInsider
ScreenerThemes
Earnings
WatchlistInsider
ZTEK
← Back to Screener
VCP ScannerFree US Stock Screener & Financial Analysis

Find stocks. Verify deeply. Act with conviction.

Data updated daily

Product

  • Screener
  • Themes
  • Valuation
  • Total Return
  • DCA Calculator
  • News
  • Earnings

Resources

  • Market Valuation
  • Compare
  • Insider Activity
  • Methodology
  • How It Works
  • Glossary
  • Learn

Get Ideas

Get weekly stock ideas — free

© 2026 VCP Scanner
AboutPrivacyTerms
Not financial advice. Do your own research.
ScreenerNewsCompareWatchlist
ZTEKZentek Ltd.
$0.46$50M
Overview & Verdict
Overview
Valuation & Forecasts
Valuation ModelsEstimatesDCF Model
Price & Analyst Data
Analyst TargetsPrice HistoryTechnical Analysis
Financial Statements
Income StatementBalance SheetCash FlowRatios & Margins
Performance
P/E HistoryRevenue HistoryEarnings HistoryDividend HistoryTotal Return
Ownership
Holders
HomeStocksZTEKBalance Sheet

Zentek Ltd. (ZTEK) Balance Sheet

17Y historyFree accessUpdated daily

The company's liquidity position is increasingly compromised, evidenced by a current ratio that compressed to 0.64 as of 2025Q4 alongside accumulated losses totaling $91.5 million.

ZTEK Balance Sheet

Income StatementBalance SheetCash FlowRatios
AnnualQuarterly
MetricMar'26Mar'25Mar'24Mar'23Mar'22Mar'21Mar'20Mar'19Mar'18Mar'17Mar'16Mar'15Mar'14Mar'13Mar'12Mar'11Mar'10
Total Current Assets2.28M4.37M4.61M17.95M25.54M3.39M1.07M1.47M172.15K1.11M515.63K493.51K2.62M6.86M3.84M9.26M2.56M
Cash & Short-Term Investments1.31M121.48K2.6M10.36M21.32M3.09M805.95K1.22M96.74K997.25K432.46K369.79K1.93M6.61M3.67M9.1M2.52M
Cash Only1.31M121.48K384.91K10.36M21.16M3.09M805.95K1.22M96.74K383.97K169.6K132.49K626.63K5.32M1.11M550.38K2.12M
Short-Term Investments002.21M0159.84K0000613.28K262.86K237.3K1.3M1.29M2.56M8.55M400.18K
Accounts Receivable372.21K1.2M619.93K6.46K2.88M119.35K77.54K217.14K0053.88K98.92K655.83K216.73K152.71K132.86K33.11K
Days Sales Outstanding816.07503.167.59K32.353.1K18.5K-----------
Inventory418.62K887.51K1.05M2.96M531.92K000000000000
Days Inventory Outstanding23.62476.381.16K1.27K515.28------------
Other Current Assets186.2K1.88M343.82K3.55M809.08K000000000000
Total Non-Current Assets12.84M14.03M12.06M15.34M10.41M26.86M25.16M24.08M22.05M21.69M21.03M20.1M18.68M10.09M7.42M2.89M637.12K
Property, Plant & Equipment4.67M12.73M5.74M15.34M4.82M26.86M25.16M24.08M22.05M21.69M21.03M20.1M18.68M10.09M7.42M23.82K0
Fixed Asset Turnover0.04x0.07x0.01x0.00x0.07x0.00x-----------
Goodwill00000000000000000
Intangible Assets00000000000000000
Long-Term Investments00000000000000000
Other Non-Current Assets8.18M1.29M6.32M05.59M00-24.08M00000002.87M574.62K
Total Assets15.13M18.4M16.67M33.29M35.95M30.25M26.24M25.54M22.22M22.8M21.54M20.6M21.29M16.95M11.26M12.15M3.2M
Asset Turnover0.01x0.05x0.00x0.00x0.01x0.00x-----------
Asset Growth %-17.78%10.34%-49.92%-7.41%18.85%15.29%2.73%14.93%-2.51%5.81%4.6%-3.27%25.64%50.47%-7.3%280.09%-
Total Current Liabilities3.54M3.48M1.34M2.42M1.84M2.51M527.58K646.64K152.03K83.3K91.04K180.92K272.33K500.56K1.03M1.01M155.9K
Accounts Payable2.09M2.01M399.6K911.48K834.83K348.1K390.9K621.64K127.03K58.3K66.04K155.92K187.33K460.91K998.57K671.46K0
Days Payables Outstanding117.911.08K440.53389.87808.72648.168.16K42.84K7.64K2.19K2.12K------
Short-Term Debt162.15K346.75K479.64K998.08K879.32K000000000000
Deferred Revenue (Current)00000000000000000
Other Current Liabilities1.28M0463.55K1127.87K2.01M111.68K00000000315.2K155.9K
Current Ratio0.64x1.25x3.44x7.42x13.87x1.35x2.04x2.27x1.13x13.28x5.66x2.73x9.61x13.71x3.75x9.15x16.42x
Quick Ratio0.53x1.00x2.65x6.19x13.58x1.35x2.04x2.27x1.13x13.28x5.66x2.73x9.61x13.71x3.75x9.15x16.42x
Cash Conversion Cycle721.78-97.698.31K910.22.8K------------
Total Non-Current Liabilities1.76M161.74K437.63K484.86K903.6K281.87K0000000010.7K00
Long-Term Debt1.76M0191.28K0797.66K000000000000
Capital Lease Obligations0161.74K246.36K484.86K387.5K281.87K00000000000
Deferred Tax Liabilities0000000000000010.7K00
Other Non-Current Liabilities0000-281.56K0000000000-315.2K0
Total Liabilities5.3M3.65M1.78M2.9M2.75M2.79M527.58K646.64K152.03K83.3K91.04K180.92K272.33K500.56K1.04M1.01M155.9K
Total Debt1.92M680.47K917.27K1.61M2.06M404.32K00000000000
Net Debt611.89K558.99K532.36K-8.75M-19.09M-2.69M-805.95K-1.22M-96.74K-383.97K-169.6K-132.49K-626.63K-5.32M-1.11M-550.38K-2.12M
Debt / Equity0.20x0.05x0.06x0.05x0.06x0.01x-----------
Debt / EBITDA-----------------
Net Debt / EBITDA-----------------
Interest Coverage-37.44x-108.94x-108.93x-118.50x-495.95x-400.80x-------653.83x----
Total Equity9.83M14.75M14.89M30.38M33.21M27.46M25.71M24.9M22.07M22.71M21.45M20.42M21.02M16.45M10.23M11.14M3.04M
Equity Growth %-33.37%-0.96%-50.99%-8.5%20.91%6.81%3.28%12.79%-2.82%5.87%5.08%-2.88%27.81%60.82%-8.18%266.3%-
Book Value per Share0.090.140.150.310.360.330.330.370.350.370.370.360.390.400.260.400.14
Total Shareholders' Equity9.83M14.75M14.89M30.38M33.21M27.46M25.71M24.9M22.07M22.71M21.45M20.42M21.02M16.45M10.23M11.14M3.04M
Common Stock92.54M89.48M63.56M85.75M68.33M43.8M40.21M38.31M34.18M33.77M31.18M28.06M26.42M19.06M000
Retained Earnings-91.46M-83.85M-56.56M-66.2M-41.7M-20.49M-16.9M-16.31M-18.01M-18.2M-15.58M-12.07M-9.06M-5.54M-3.22M-1.39M-147.95K
Treasury Stock00000000000000000
Accumulated OCI8.74M6.34M7.89M10.83M6.58M001.75M4.94M6.23M5.23M3.84M3.07M2.04M000
Minority Interest00000000000000000

Key Metrics

Growth RegimeMixed
ProfitabilityNegative
Balance SheetVulnerable
Cash FlowBurning
Top Statement Risk

Acute liquidity and dilution

Liquidity Buffer Nearing Critical Depletion

As reported in recent financial statements, Zentek's cash position has dwindled to $1.3 million as of 2025Q4, while the current ratio has compressed to 0.64, indicating that the company's ability to cover short-term obligations without external financing appears increasingly compromised by persistent operational cash burn.

The rapid decline in the current ratio from historical highs above 6.0 suggests that the company has exhausted its initial capital cushion. Investors should monitor the company's ability to secure non-dilutive funding, as the current liquidity profile leaves little room for operational delays or unforeseen capital requirements.

Leverage Remains Low Despite Insolvency Risks

Based on reported figures, Zentek maintains a debt-to-equity ratio of 0.20, which, while appearing conservative on the surface, masks the underlying reality that the company's limited cash flow durability makes even modest debt levels a potential burden on its already strained financial position.

The company's reliance on debt appears to be a necessity-driven measure rather than a strategic capital allocation choice. Given the negative retained earnings of $91.5 million, the current debt load warrants further investigation into the restrictive covenants that may limit management's flexibility during this critical commercialization phase.

Equity Erosion Through Persistent Deficits

According to the latest balance sheet data, Zentek's equity base has been significantly eroded by accumulated losses, with retained earnings reaching negative $91.5 million, a trend that suggests the company's primary source of funding has been shareholder dilution rather than internal value creation.

The consistent expansion of the deficit in retained earnings highlights the high cost of the company's R&D-heavy business model. This trajectory suggests that shareholders may face continued dilution as the firm attempts to bridge the gap between its current commercial output and the scale required for profitability.

Asset Valuation Risks and Capitalization

Data from recent filings indicates that Zentek's asset base is heavily concentrated in PPE, which fluctuated significantly from $12.8 million to $4.7 million in recent quarters, suggesting that the carrying value of these assets may be subject to impairment risks if commercial adoption fails to materialize.

The volatility in reported PPE values may imply that the company is adjusting its asset base to reflect the shifting focus of its Albany Graphite project. Investors should be cautious, as the lack of goodwill on the balance sheet does not necessarily preclude the risk of future write-downs if the underlying technology fails to achieve broader market integration.

ZTEK — Frequently Asked Questions

Quick answers to the most common questions about buying ZTEK stock.

What are the total assets of Zentek Ltd. (ZTEK)?

As of 2025, Zentek Ltd. (ZTEK) had total assets of $15.1M including $2.3M in current assets.

How much debt does Zentek Ltd. (ZTEK) have?

Zentek Ltd. (ZTEK) carries total debt of $1.9M, offset by $1.3M in cash and short-term investments. Comparing total debt to cash helps evaluate the company's debt burden and net leverage.

What is the book value or shareholders' equity of Zentek Ltd.?

Zentek Ltd. (ZTEK) has total shareholders' equity (book value) of $9.8M ($0.09 book value per share). Book value represents the net worth of the company belonging to common stock holders.

What is Zentek Ltd.'s current ratio and liquidity?

Zentek Ltd. (ZTEK) reported a current ratio of 0.64x. A current ratio above 1.0x indicates that the company has more current assets than current liabilities, suggesting sufficient short-term liquidity.